SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-056302
Filing Date
2022-11-09
Accepted
2022-11-09 20:30:16
Documents
2
Period of Report
2022-11-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3010
2 POA DOCUMENT poa.txt EX-24 3614
  Complete submission text file 0001209191-22-056302.txt   7971
Mailing Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 617-207-8979
Acrivon Therapeutics, Inc. (Issuer) CIK: 0001781174 (see all company filings)

IRS No.: 825125532 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACRIVON THERAPEUTICS, INC. 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472
Business Address
Holm-Jorgensen Rasmus (Reporting) CIK: 0001950496 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41551 | Film No.: 221374536